Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,769.34
(
0.36%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Monday, 08/13/2007 8:43:39 AM

Monday, August 13, 2007 8:43:39 AM

Post# of 19309
Addressable Market for ATryn in DIC/Sepsis:

There are approximately 250,000 cases of DIC/sepsis annually in the US and a similar number in Europe (#msg-19928950).

(The number of cases in the US and Europe of severe sepsis per se, with or without DIC, is about 1.5 million annually: #msg-17411076.)

Considering the US market only (where GTC owns 100% of the commercial rights) and assuming a price per treatment of $10,000-$12,000, the addressable market size is (250K)x($10-12K) = $2.5-$3B (#msg-19928950, #msg-22015291).

GTC experts to be able to capture at least $1B of this market opportunity (#msg-19928950).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now